About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank


« JPO and USPTO Announce PCT and Search Collaborations | Main | Biotech-specific Subject Matter Eligibility Materials Delayed »

July 29, 2015



As Skeptical might say: "I Remain [Skeptical]."

Comments are available now as indicated in the posting.

Much for our colleagues in computer science and business methods. Not much yet for the biotech area, but the USPTO says they are digesting Ariosa - watch that space.

When the pharma/biotech comments come out, what is the betting that they will finally drop the Amazonic Acid example?

"what is the betting that they will finally drop the Amazonic Acid example?"


I predict "slim and none" even though that example is utterly absurd.

The comments to this entry are closed.

May 2024

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31